Literature DB >> 15598697

The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function.

K J Barber1, J A Franklyn, C J McCabe, F L Khanim, J N Bulmer, G S J Whitley, M D Kilby.   

Abstract

The development of the human placenta involves a complex process of tightly regulated proliferation and invasion by extravillous trophoblast into the uterine decidua. Inadequate placentation is a feature of intrauterine growth restriction and other gestational pathology. There is some evidence that T(3) plays a role in the regulation of these processes and that T(3) may act synergistically with epidermal growth factor (EGF). The aim of this study was to define the expression of thyroid hormone receptors in extravillous trophoblast, elucidate the effects of T(3) on both proliferation and differentiation of human trophoblast cells of varying origins, and define the potential interaction between EGF and T(3) on these processes. Using immunohistochemistry, specific thyroid hormone receptor isoforms were localized in extravillous trophoblast in first- and second-trimester placental bed biopsies, indicating potential sensitivity to T(3). In studies of human trophoblast-derived cell lines and primary cultures of cytotrophoblast cells in vitro, T(3) and EGF exerted an antiproliferative effect on an extravillous-like cell line (SGHPL-4) but stimulated proliferation in JEG-3 choriocarcinoma cells. EGF enhanced survival of nonproliferative term primary cytotrophoblast cells and significantly enhanced invasion of fibrin gels by SGHPL-4 cells, an effect attenuated by T(3). Both T(3) and EGF also significantly enhanced SGHPL-4 motility. These results suggest that EGF and T(3) may act synergistically to regulate both proliferation and differentiated function of human trophoblast.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598697     DOI: 10.1210/jc.2004-0785

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

2.  Subclinical Changes in Maternal Thyroid Function Parameters in Pregnancy and Fetal Growth.

Authors:  Lauren E Johns; Kelly K Ferguson; David E Cantonwine; Bhramar Mukherjee; John D Meeker; Thomas F McElrath
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

Review 3.  Biological features of placental programming.

Authors:  Kent L Thornburg; Kevin Kolahi; Melinda Pierce; Amy Valent; Rachel Drake; Samantha Louey
Journal:  Placenta       Date:  2016-10-20       Impact factor: 3.481

4.  Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort.

Authors:  Tuija Männistö; Pauline Mendola; Jagteshwar Grewal; Yunlong Xie; Zhen Chen; S Katherine Laughon
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

5.  Endocrine disruption in human placenta: expression of the dioxin-inducible enzyme, CYP1A1, is correlated with that of thyroid hormone-regulated genes.

Authors:  Thomas L Wadzinski; Katherine Geromini; Judy McKinley Brewer; Ruby Bansal; Nadia Abdelouahab; Marie-France Langlois; Larissa Takser; R Thomas Zoeller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 6.  Regulation of the cardiomyocyte population in the developing heart.

Authors:  Kent Thornburg; Sonnet Jonker; Perrie O'Tierney; Natasha Chattergoon; Samantha Louey; Job Faber; George Giraud
Journal:  Prog Biophys Mol Biol       Date:  2010-12-13       Impact factor: 3.667

7.  Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases.

Authors:  Heather L LaMarca; Philip R Dash; Keshika Vishnuthevan; Evelyn Harvey; Deborah E Sullivan; Cindy A Morris; Guy St J Whitley
Journal:  Hum Reprod       Date:  2008-05-16       Impact factor: 6.918

8.  Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.

Authors:  S-Y Chan; J A Franklyn; H N Pemberton; J N Bulmer; T J Visser; C J McCabe; M D Kilby
Journal:  J Endocrinol       Date:  2006-06       Impact factor: 4.286

9.  Monocarboxylate transporter 8 modulates the viability and invasive capacity of human placental cells and fetoplacental growth in mice.

Authors:  Elisavet Vasilopoulou; Laurence S Loubière; Heike Heuer; Marija Trajkovic-Arsic; Veerle M Darras; Theo J Visser; Gendie E Lash; Guy S Whitley; Christopher J McCabe; Jayne A Franklyn; Mark D Kilby; Shiao Y Chan
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

Review 10.  Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.

Authors:  Shakila Thangaratinam; Alex Tan; Ellen Knox; Mark D Kilby; Jayne Franklyn; Arri Coomarasamy
Journal:  BMJ       Date:  2011-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.